News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis International AG (NVS) Says EU Approves Inflammatory Disease Drug


10/28/2009 8:27:25 AM

Reuters -- The European Union has approved Novartis AG's Ilaris to treat children and adults with a rare but potentially fatal inflammatory disease, the Swiss drugmaker said on Wednesday. Novartis said in a statement the accelerated EU decision follows approvals in the United States and Switzerland.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES